Skip Nav Destination
Issues
1 May 2007
-
Cover Image
Cover Image
Molecular changes arising from lapatinib treatment on breast cancer cell lines were examined using whole genome microarrays. Protein-protein and protein-gene interactions involving AKT and genes downstream of AKT were identified using the Ingenuity Pathways Knowledge base, TransFac, TRRD, and HPRD databases. Positive-interacting proteins are connected by red arrows, negative-interacting proteins are connected by green arrows, and protein-DNA binding interactions are indicated by black arrows. Kinases are shown in yellow, enzymes in red, and transcription factors in teal. Genes that do not represent a particular target class are shown in grey. For details, see Hegde et al. in this issue. - PDF Icon PDF LinkTable of Contents
ISSN 1535-7163
EISSN 1538-8514
Obituary
Spotlight on Clinical Response
Spotlight on Molecular Profiling
Research Articles: Therapeutics, Targets, and Development
Defining regional infusion treatment strategies for extremity melanoma: comparative analysis of melphalan and temozolomide as regional chemotherapeutic agents
Yasunori Yoshimoto; Christina K. Augustine; Jin S. Yoo; Patricia A. Zipfel; M. Angelica Selim; Scott K. Pruitt; Henry S. Friedman; Francis Ali-Osman; Douglas S. Tyler
Development of two novel benzoylphenylurea sulfur analogues and evidence that the microtubule-associated protein tau is predictive of their activity in pancreatic cancer
Antonio Jimeno; Gurulingappa Hallur; Audrey Chan; Xiangfeng Zhang; George Cusatis; Fonda Chan; Preeti Shah; Rongbing Chen; Ernest Hamel; Elizabeth Garrett-Mayer; Saeed Khan; Manuel Hidalgo
Enhanced tumor cell kill by combined treatment with a small-molecule antagonist of mouse double minute 2 and adenoviruses encoding p53
Harm C.A. Graat; Jan E. Carette; Frederik H.E. Schagen; Lyubomir T. Vassilev; Winald R. Gerritsen; Gertjan J.L. Kaspers; Paul I.J.M. Wuisman; Victor W. van Beusechem
Rad51 overexpression contributes to chemoresistance in human soft tissue sarcoma cells: a role for p53/activator protein 2 transcriptional regulation
Jonathan A.F. Hannay; Juehui Liu; Quan-Sheng Zhu; Svetlana V. Bolshakov; Lan Li; Peter W.T. Pisters; Alexander J.F. Lazar; Dihua Yu; Raphael E. Pollock; Dina Lev
Transactivator of transcription–tagged cell cycle and apoptosis regulatory protein-1 peptides suppress the growth of human breast cancer cells in vitro and in vivo
Liyue Zhang; Edi Levi; Pralay Majumder; Yingjie Yu; Amro Aboukameel; Jianhua Du; Hu Xu; Ramzi Mohammad; James S. Hatfield; Anil Wali; Volkan Adsay; Adhip P.N. Majumdar; Arun K. Rishi
Correction
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.